COVID Intel - by William Makis (McGill Medicine)

CANCER RESEARCH - TOCOTRIENOLS - 2025 Review - Therapeutic Potential of Tocotrienols as Chemosensitizers in Cancer Therapy (Why They Are...

The 2025 review examines tocotrienols, a subset of vitamin E, as chemosensitizers that boost the effectiveness of conventional cancer drugs. Pre‑clinical studies show that combining tocotrienols with antiparasitic agents such as fenbendazole or mebendazole markedly increases tumor cell death. The analysis highlights delta‑tocotrienol’s superior antioxidant and anti‑inflammatory properties, which appear to underlie the synergistic effects. Although early data are promising, human trials are still needed to confirm safety and dosing protocols.